ASE·Healthcare·$97M·#334 / 520 in Healthcare
PTHS Pelthos Therapeutics Inc.
35HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY37
STABILITY25
VALUATION85
GOVERNANCE67
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
N/A
0
> 50% strong
Gross Margin
Revenue retained after direct costs
44.2%
61
> 50% strong
Cash Runway
Months of cash at current burn rate
10 months
28
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
89.6%
19
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.5x
85
< 3x strong
Rule of 40
Growth rate plus operating margin
N/A
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
53.8%
100
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+436.0%
0
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE PTHS WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when PTHS's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.